Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT

Clinical trial NCT04804007 · RECRUITING

Trial details

NCT number: NCT04804007
Sponsor: Nabil Adra
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumor Non-seminomatous Germ Cell Tumor Ovarian Germ Cell Tumor

Start date: 2021-03-03
Primary completion: 2027-12-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.